Greencare Capital - Appointment of Non-Executive Director

20 September 2021

Greencare Capital PLC

("Greencare" or the "Company")

Board Change:

Appointment of Non-Executive Director

Greencare (AQSE: GRE), the investment company focused on investing in medicinal cannabis, CBD and related wellness areas, is pleased to announce the appointment of Ms Monica Formenti to the Board as a Non-Executive Director with immediate effect.

Ms Formenti qualified as a Lawyer in 2009 in Milan, Italy, and has practiced corporate and commercial law for a number of multi-national organisations since then. She is currently a director of an international corporate advisory firm in Milan, providing wide-ranging advice on all legal matters relating to corporate and civil law, including corporate governance, commercial agreements, M&A and corporate finance.

Previously she worked for 11 years at PPG Industries Inc based in Milan, part of a multinational organisation operating in the chemicals industry as Head of its Legal Department. This included dealing with all legal and corporate/compliance issues, commercial contracts and other regulatory matters including the management of shareholder meetings.

Commenting on Ms. Formenti's appointment, Greencare CEO, Richard Tonthat, said:

"I am delighted to welcome Monica to the Greencare Board. We operate in a heavily regulated sector and market, and so Monica's extensive cross-border corporate and commercial legal advisory experience, particularly as a legal compliance expert, will be of great value as we continue to build our investment portfolio."

The following information is disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Monica Formenti (aged 47) holds or has held the following directorships or partnerships in the past five years:

Ms Formenti does not hold any shares in the Company. There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Rulebook.

Enquiries:

Notes:

Greencare Capital plc is an investment company quoted on the Aquis Stock Exchange Growth Market ("AQSE"). The Company was incorporated on 1 October 2019 and its shares were admitted to trading on 30 December 2019.

The Company's investment strategy is to focus on investments in cannabis sectors within countries predominantly in Europe whose jurisdictions have well-developed and reputable laws and regulations for its production, research and distribution; together with the CBD and hemp sectors.

The Company will invest directly or indirectly in public or private companies, in supply and distribution chains, or other business associated with the cannabis sector. Investments may take the form of debt or equity and it is expected that such investments will ordinarily seek capital growth in the medium term in preference to income.

The Company will not invest in the recreational cannabis sector, or in entities or activities supported by it, nor any other related activities which would be deemed illegal under UK legislation.